Posters

Time

Thursday, June 8, 2023

10:00 - 10:30

Poster Session 1 - Arrythmias and Device Therapy

P1-1 Success rate of left bundle branch area pacing in 100 consecutive patients

Jarkko Karvonen

P1-2 Deep learning algorithm on single-lead ECG to stratify risk of shockable cardiac arrest among hospitalized patients

Eno-Martin Lotman

P1-3 Impact of cryoablation on the quality of life of patients with atrial fibrillation

Greta Radauskaite

P1-4 Amiodarone induced thyroid dysfunction

Páll Guðjónsson

P1-5 Systemic atherosclerosis causes reduced cerebral perfusion

Marianna Gardarsdottir

Poster session 2 - Arrythmias and device therapy / Basic science

P2-2 Impact of maternal connective tissue disease on conduction abnormalities in the offspring

Sarah Sofie Andersen

P2-3 Impact of cardiac devices on Quality of Life

Paolo Gatti

P2-4 Reduced liver fat and improved cardiometabolic health in individuals with non alcoholic fatty liver disease after a 12 week  digital health program - a feasibility study

Sigríður  Björnsdóttir

P2-5 Myocardial stunning model in rats

Ahmed Elmahdy

Poster session 3 - Imaging / Basic science

P3-2 Valvular Keloids? Aggressive Scarring Process Leading to Multivalvular Obstruction

Nikhil Kolluri

P3-3 Non-invasive assessments reveal that > 50 % of newly diagnosed asymptomatic patients with type-2 diabetes mellitus have subclinical atherosclerosis.

Gulia  Faizi

P3-4 Incidence rates of cardiovascular disease in Greenland 1994 - 2020

Hjalte Erichsen Larsen

15:00 - 15:30

Poster session 4 - Coronary artery disease

P4-1 A digital health program is feasible for outpatient care in coronary artery disease

Davíð Ottó Arnar

P4-2 Online cognitive behavioral therapy targeting cardiac anxiety following myocardial infarction: rational and design of a randomized control trial

Amanda Johnsson

P4-3 Early changes in myocardial stunning and biomarkers after ST-elevation myocardial infarction compared to the takotsubo syndrome

Ahmed Elmahdy

P4-4 Beating Heart CABG on Intermittent Pump Support

Sushil Kumar Singh

P4-5 Decoding the Impact of SIRT1 Gene Variants in Coronary Microvascular Dysfunction following ST-Elevation Myocardial Infarction

Benas Kireilis

P4-6 “The future of coronary artery revascularization with bioresorbable stents”

Andrejs Erglis

Poster session 5 - Heart failure

P5-1 Impact of the COVID-19 pandemic on the incidence and mortality in takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry

Elmir Omerovic

P5-2 Importance of hospital and clinical factors in predicting of 30-day mortality in Takotsubo syndrome: Data from the Swedish Coronary Angiography and Angioplasty Registry

Elmir Omerovic

P5-3 Pre-implantation central hemodynamic profile of HFrEF patients receiving CRT or ICD: a two-centre controlled study

Anette Caroline Kõre

P5-4 Study of novel immunomarkers’ expression in left ventricular cardiomyocytes during remodeling in progressing heart failure (HF) of ischemic origin

Milda Kupryte

Poster session 6 - Hypertension

P6-1 Influence of nebivolol, bisoprolol and carvedilol on the penile hemodynamic in men with arterial hypertension

Gulnara Nur-Mammadova

P6-3 Prevalence of apparent treatment-resistant hypertension in Iceland and adherence to clinical practice guidelines

Kristján Harðarson

Time

Friday, June 9

10:00 - 10:30

Poster session 7 - Interventional cardiology and cardiovascular surgery

P7-1 Carotid artery stenting in a patient with high platelet reactivity due to hematologic neoplasm. A case report.

Kristina Lotamõis

P7-2 Long-term outcome after venosus-type atrial septal defect closure

Valtteri Juho Matias Muroke

P7-3 Intrahospital outcomes of true coronary bifurcation treatment. Latvian Center of Cardiology.

Eva Bolsteina

P7-4 Indications and outcomes of TAVI (transcatheter aortic valve implantation) in Iceland

Ingibjörg Guðmundsdóttir

P7-5 Percutaneous coronary intervention post transcatheter aortic valve implantation

Monér Alchay

P7-6 “One-year clinical outcomes of sirolimus-eluting bioresorbable stent implantation. Single centre real-life registry data for N=333 patients”

Andrejs Erglis

Poster session 8 - Myocardial, pericardial and valvular disease

P8-1 Myocarditis: risk factors for longer hospitalization during Covid-19 pandemic

Monika Biesevičienė

P8-2 Prognostic role of atrial fibrillation in patients with non-compaction cardiomyopathy

Nadiia Rineiska

P8-3 Leaflet mechanical stress distribution in different designs of surgical and transcatheter aortic valve bioprostheses: An in vitro study

Regis RIEU

P8-4 Left ventricular strain on ECG in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI); Insights from TAVI-NOR study

Daanyaal Wasim

P8-5 Earlier detection of significant perioperative myocardial injury after cardiac surgery

Zineb Chaabi

P8-6 Left ventricular non-compaction in childhood: echocardiographic follow-up and prevalence in first-degree relatives

Thilde Olivia Kock

15:00 - 15:30

Poster session 9 - Other I

P9-1 Heart Rhythm Control in Children and Adolescents with Psychiatric Disorders: A Pilot Study on Heart Rate Variability and Medication Use

Kamile Plesnyte Capkauskiene

P9-2 Cost analysis of treating cardiovascular diseases in a superspeciality hospital in India

Vijaydeep Siddharth

P9-3 Association between pre-operative prolonged corrected QT interval and all-cause mortality after non-cardiac surgery

Helena Xiang Jóhannsdóttir

P9-4 Autopsy findings of sudden cardiac death victims at premenopausal and postmenopausal age

Mira Anette Emilia Eskuri

P9-5 Increased Cyber Vulnerability and Need for Cyber Risk Transparency in the Informed Consent for Patients with Cardiac Implantable Electronic Devices

Leanne N.S. Torgersen

P9-6 Complex trust-building process as part of the use of technology in digital cardiac rehabilitation

Marjo-Riitta Anttila

Poster session 10 - Other II

P10-1 Impact of prior use of anthracyclines on cardiac function in patients before undergoing hematopoietic stem cell transplantation

Audrone Vaitiekiene

P10-2 The results of a 10-year longitudinal monitoring of cardiac rehabilitation patients

Maie Ojamaa

P10-3 Chronic pain after lung transplantation A nationwide study – short and long term

Jytte Graarup

P10-4 Health Self-Assessment and Cardiovascular Risk Factors in Population of Latvia. Cross-sectional study

Iveta Bajare

P10-5 Case report: Atypical developmental delay associated with Ebstein anomaly following early hypoxia or comorbidity

Loriana Kilaitė

P10-6 An acquired fistula between coronary and pulmonary arteries after heart transplantation

Anna Maria  Punab

Poster session 11 - Preventive cardiology

P11-1 Oral anticoagulant use by lifeday coverage and one-year relative survival in atrial fibrillation patients in Estonia 2019 and 2020

Priit Pauklin

P11-2 Peripheral bioimpedance curves – just a heart in a magic mirror or crystal ball for cardiovascular prevention

Kristina Lotamõis

P11-3 Expanding access to cardiac rehabilitation: a remote service model for heart disease patients

Mattias Tralla

P11-4 Is statin lipid-lowering therapy sufficient for LDL-C goal attainment in very high cardiovascular risk Lithuanians?

Jolita Badariene

P11-5 Non-participants in cardiac rehabilitation; -why 47% don´t participate in cardiac rehabilitation

Nanna Nørgaard Eg

Congress secretariat

Lógó Athygli ráðstefnur

 

Athygli Conferences
Armula 11
108 Reykjavík
Iceland

+(354) 568 2800

About